Compare CSBR & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | FRD |
|---|---|---|
| Founded | 1985 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.7M | 134.3M |
| IPO Year | 2015 | 1995 |
| Metric | CSBR | FRD |
|---|---|---|
| Price | $5.74 | $17.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.7K | ★ 24.7K |
| Earning Date | 03-12-2026 | 02-09-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | ★ 161.11 | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | $2,900,000.00 | ★ $121,157,278.00 |
| Revenue This Year | $4.84 | N/A |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | ★ N/A | $12.34 |
| Revenue Growth | N/A | ★ 55.82 |
| 52 Week Low | $5.50 | $12.24 |
| 52 Week High | $9.63 | $24.37 |
| Indicator | CSBR | FRD |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 44.76 |
| Support Level | $5.50 | $16.26 |
| Resistance Level | $6.29 | $22.82 |
| Average True Range (ATR) | 0.27 | 0.90 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 23.81 | 51.49 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.